Trials / Completed
CompletedNCT07432763
Effects of Pomegranate Seed Oil Supplementation in Patients With Advanced Dementia
Effects of a Twenty-Four-Week Pomegranate Seed Oil Supplementation in Palliative Care Patients With Advanced Dementia: A Double Blind, Randomized Controlled Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Panhellenic Federation of Alzheimer's Disease and Related Disorders · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical study is to learn if Pomegranate Seed Oil supplementation works to combat urinary tract infections, recurrenturinary tract infections, or pneumonia and contributes to the tapering or discontinuation of antipsychotics in palliative care patients withadvanced dementia. The main questions it aims to answer are: * Does Pomegranate Seed Oil supplementation reduce the likelihood of developing a urinary tract infection? * Does Pomegranate Seed Oil supplementation prevent UTI reinfection? * Does Pomegranate Seed Oil supplementation reduce the likelihood of pneumonia? * Does Pomegranate Seed Oil supplementation contribute to the tapering or discontinuation of antipsychotics? Researchers will compare Pomegranate Seed Oil to care-as-usual to see if Pomegranate Seed Oil supplementation can increase quality of care in palliative care patients with advanced dementia.
Conditions
- Urinary Tract Infections (UTIs)
- Urinary Tract Infection, Recurrent
- Antipsychotics Discontinuation
- Antipsychotics Tapering
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Pomegranate Seed Oil Supplementation in Palliative Care Patients with Advanced Dementia | Besides Pomegranate Seed Oil Supplementation, all participants will continue to receive all ongoing care and treatments, including following the Mediterranean diet, monthly neuropsychological and behavioural assessments, physiotherapy, cognitive stimulation, occupational therapy and music therapy, without any modification |
| OTHER | Care-as-usual | All participants will continue to receive all ongoing care and treatments, including a Mediterranean diet,monthly neuropsychological and behavioural assessments, physiotherapy, cognitive stimulation,occupational therapy and music therapy, without any modification |
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2024-10-31
- Completion
- 2024-10-31
- First posted
- 2026-02-25
- Last updated
- 2026-02-25
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT07432763. Inclusion in this directory is not an endorsement.